 |
Kojin Therapeutics
Last updated: October 06, 2024
Founders: Stuart Schreiber, Vasanthi Viswanathan
USA | Funding: $60M (+)
Website: https://kojintx.com/
Kojin Therapeutics is developing transformative medicines based on a groundbreaking approach to ferroptosis and cell state biology. Our approach opens new avenues for the treatment of cancer, fibrosis, ischemia, and immune modulation.
Website: https://kojintx.com/
Kojin Therapeutics is developing transformative medicines based on a groundbreaking approach to ferroptosis and cell state biology. Our approach opens new avenues for the treatment of cancer, fibrosis, ischemia, and immune modulation.
